Re: Broker Meeting 23 Feb

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Broker Meeting 23 Feb

in response to

Re: Broker Meeting 23 Feb

BearDownAZ

posted on Mar 01, 2017 12:50PM

BDAZ - I posted what I had heard from the 3 sources so I can not comment on anything else. If someone has access to notes made at this meeting it would be great if they could post them.